CDK1 and ovarian cancer: We propose a model in which CDK1 and CDK2 phosphorylate MLK3, and this phosphorylation works as a “on/off” switch that in turn regulates MLK3 and JNK activity to control cell cycle progression in ovarian cancer cells (Fig. 6).